chr1-27945270-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014474.4(SMPDL3B):c.100G>A(p.Asp34Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000483 in 1,614,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014474.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPDL3B | NM_014474.4 | c.100G>A | p.Asp34Asn | missense_variant | 2/8 | ENST00000373894.8 | |
SMPDL3B | NM_001009568.3 | c.100G>A | p.Asp34Asn | missense_variant | 2/7 | ||
SMPDL3B | XM_011541259.3 | c.190G>A | p.Asp64Asn | missense_variant | 3/9 | ||
SMPDL3B | NM_001304579.2 | c.-590G>A | 5_prime_UTR_variant | 2/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPDL3B | ENST00000373894.8 | c.100G>A | p.Asp34Asn | missense_variant | 2/8 | 1 | NM_014474.4 | P1 | |
ENST00000448015.1 | n.287-6191C>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152154Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000298 AC: 75AN: 251382Hom.: 0 AF XY: 0.000309 AC XY: 42AN XY: 135860
GnomAD4 exome AF: 0.000484 AC: 708AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.000469 AC XY: 341AN XY: 727246
GnomAD4 genome AF: 0.000466 AC: 71AN: 152272Hom.: 0 Cov.: 31 AF XY: 0.000443 AC XY: 33AN XY: 74442
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 23, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at